Sarah A. O'Dowd - 27 May 2021 Form 4 Insider Report for Protagonist Therapeutics, Inc (PTGX)

Role
Director
Signature
/s/ Donald Kalkofen, Attorney-in-Fact for Sarah A. O'Dowd
Issuer symbol
PTGX
Transactions as of
27 May 2021
Transactions value $
$0
Form type
4
Filing time
28 May 2021, 18:50:06 UTC
Previous filing
14 May 2021
Next filing
26 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTGX Stock Option (right to buy) Award $0 +18,000 $0.000000 18,000 27 May 2021 Common Stock 18,000 $35.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest at the earlier of (i) May 27, 2022, or (ii) the date of the 2022 Annual Meeting of stockholders of the Issuer, subject to the non-employee director's continuous service with the Issuer through such dates. The shares subject to this option will vest in full upon completion of a Change in Control (as defined in the Issuer's 2016 Equity Incentive Plan).